A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Status:
Recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
Purposeļ¼1. Preliminary evaluation of the preventive effect of DH001 on doxorubicin-induced
cardiotoxicity in cancer patients 2.To explore appropriate dosages to provide basis for
dosages in subsequent confirmatory studies 3.To evaluate the effect of DH001 on the efficacy
of doxorubicin treatment in cancer patients 4.To evaluate the safety of DH001 in cancer
patients treated with doxorubicin